<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>213-ESTRAMUSTINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ESTRAMUSTINE" rxcui="4089">
<ATC code="L01XX11" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="CLODRONIC ACID" rxcui="3350">
<ATC code="M05BA02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of increase of the plasma concentrations of estramustine by the clodronate</DESCRIPTION>
<SEVERITY>Precaution for use:</SEVERITY>
<COMMENT>Clinical monitoring during the administration of these substances together. </COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>213-ESTRAMUSTINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ESTRAMUSTINE" rxcui="4089">
<ATC code="L01XX11" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="CALCIUM" rxcui="1428011">
<ATC code="A12AA" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the digestive absorption of the estramustine</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Take the calcium salts at a different time from the estramustine (more than 2 hours apart if possible).</COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>213-ESTRAMUSTINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ESTRAMUSTINE" rxcui="4089">
<ATC code="L01XX11" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="ANGIOTENSIN CONVERTING ENZYME INHIBITORS (ACE INHIBITORS)" code="C09AA" /></DRUG2>
<DESCRIPTION>Risk of increase of the undesirable effects of the angioneurotic edema type (angioedema)</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
</INTERACTIONS>
